Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SIM Acquisition Corp. I is a blank check company, also known as a special purpose acquisition company (SPAC), formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, or similar business combination. While the company may pursue an initial business combination in any industry, it specifically intends to focus its search on companies within the healthcare sector. The firm is sponsored by Sauvegarder Investment Management (SIM), a multi-strategy investment firm dedicated to intellectual property-related financing and investment opportunities. SIM Acquisition Corp. I aims to leverage the expertise of its management team and sponsor to identify high-value targets in the life sciences and healthcare technology markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIM Equity.